Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Lipoprotein Subfractions Associated with Endothelial Function in Previously Healthy Subjects with Newly Diagnosed Sleep Apnea-A Pilot Study

A. Hluchanova, B. Kollar, K. Klobucnikova, M. Hardonova, M. Poddany, I. Zitnanova, M. Dvorakova, K. Konarikova, M. Tedla, M. Urik, P. Klail, P. Skopek, P. Turcani, P. Siarnik

. 2023 ; 13 (2) : . [pub] 20230204

Status not-indexed Language English Country Switzerland

Document type Journal Article

BACKGROUND: Obstructive sleep apnea (OSA) activates several pathophysiological mechanisms which can lead to the development of vascular diseases. Endothelial dysfunction (ED) is an initial step in the development of atherosclerosis. The association between ED and OSA has been described in several studies, even in previously healthy subjects. High-density lipoproteins (HDL) were generally considered to be atheroprotective, and low-density lipoprotein (LDL) to be an atherogenic component of lipoproteins. However, recent findings suggest a pro-atherogenic role of small HDL subfractions (8-10) and LDL subfractions (3-7). This study aimed to evaluate the relationship between endothelial function and lipid subfractions in previously healthy OSA subjects. MATERIAL AND METHODS: We prospectively enrolled 205 subjects with sleep monitoring. Plasma levels of triacylglycerols, total cholesterol, LDL, HDL, and their subfractions were assessed. Endothelial function was determined using peripheral arterial tonometry, and reperfusion hyperemia index (RHI) was assessed. RESULTS: Plasma levels of small and intermediate HDL subfractions have statistically significant pro-atherogenic correlations with endothelial function (p = 0.015 and p = 0.019). In other lipoprotein levels, no other significant correlation was found with RHI. In stepwise multiple linear regression analysis, small HDL (beta = -0.507, p = 0.032) was the only significant contributor in the model predicting RHI. CONCLUSIONS: In our studied sample, a pro-atherogenic role of small HDL subfractions in previously healthy subjects with moderate-to-severe OSA was proven.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002997
003      
CZ-PrNML
005      
20250507132406.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/life13020441 $2 doi
035    __
$a (PubMed)36836798
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hluchanova, Alzbeta $u Department of Neurology, University Hospital Bratislava, 85107 Bratislava, Slovakia
245    10
$a Lipoprotein Subfractions Associated with Endothelial Function in Previously Healthy Subjects with Newly Diagnosed Sleep Apnea-A Pilot Study / $c A. Hluchanova, B. Kollar, K. Klobucnikova, M. Hardonova, M. Poddany, I. Zitnanova, M. Dvorakova, K. Konarikova, M. Tedla, M. Urik, P. Klail, P. Skopek, P. Turcani, P. Siarnik
520    9_
$a BACKGROUND: Obstructive sleep apnea (OSA) activates several pathophysiological mechanisms which can lead to the development of vascular diseases. Endothelial dysfunction (ED) is an initial step in the development of atherosclerosis. The association between ED and OSA has been described in several studies, even in previously healthy subjects. High-density lipoproteins (HDL) were generally considered to be atheroprotective, and low-density lipoprotein (LDL) to be an atherogenic component of lipoproteins. However, recent findings suggest a pro-atherogenic role of small HDL subfractions (8-10) and LDL subfractions (3-7). This study aimed to evaluate the relationship between endothelial function and lipid subfractions in previously healthy OSA subjects. MATERIAL AND METHODS: We prospectively enrolled 205 subjects with sleep monitoring. Plasma levels of triacylglycerols, total cholesterol, LDL, HDL, and their subfractions were assessed. Endothelial function was determined using peripheral arterial tonometry, and reperfusion hyperemia index (RHI) was assessed. RESULTS: Plasma levels of small and intermediate HDL subfractions have statistically significant pro-atherogenic correlations with endothelial function (p = 0.015 and p = 0.019). In other lipoprotein levels, no other significant correlation was found with RHI. In stepwise multiple linear regression analysis, small HDL (beta = -0.507, p = 0.032) was the only significant contributor in the model predicting RHI. CONCLUSIONS: In our studied sample, a pro-atherogenic role of small HDL subfractions in previously healthy subjects with moderate-to-severe OSA was proven.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kollar, Branislav $u 1st Department of Neurology, Faculty of Medicine, Comenius University, University Hospital, 81499 Bratislava, Slovakia $1 https://orcid.org/0000000270166992
700    1_
$a Klobucnikova, Katarina $u 1st Department of Neurology, Faculty of Medicine, Comenius University, University Hospital, 81499 Bratislava, Slovakia
700    1_
$a Hardonova, Miroslava $u 1st Department of Neurology, Faculty of Medicine, Comenius University, University Hospital, 81499 Bratislava, Slovakia
700    1_
$a Poddany, Michal $u Department of Neurology, General Hospital, 03123 Liptovsky Mikulas, Slovakia
700    1_
$a Zitnanova, Ingrid $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 81499 Bratislava, Slovakia
700    1_
$a Dvorakova, Monika $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 81499 Bratislava, Slovakia $1 https://orcid.org/0000000248730235
700    1_
$a Koňariková, Katarina, $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 81499 Bratislava, Slovakia $d 1982- $7 xx0332077
700    1_
$a Tedla, Miroslav $u Department of ENT and HNS, Faculty of Medicine, Comenius University, University Hospital, 81499 Bratislava, Slovakia $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2SQ, UK
700    1_
$a Urik, Milan $u Department of Pediatric Otorhinolaryngology, University Hospital Brno, 61300 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $1 https://orcid.org/000000022872185X
700    1_
$a Klail, Pavel, $u Department of Otorhinolaryngology, University Hospital in Pilsen, Faculty of Medicine, Charles University, 11000 Pilsen, Czech Republic $d 1995- $7 xx0328572
700    1_
$a Skopek, Petr $u Department of Otorhinolaryngology, University Hospital in Pilsen, Faculty of Medicine, Charles University, 11000 Pilsen, Czech Republic
700    1_
$a Turcani, Peter $u 1st Department of Neurology, Faculty of Medicine, Comenius University, University Hospital, 81499 Bratislava, Slovakia $1 https://orcid.org/0000000248686836
700    1_
$a Siarnik, Pavel $u 1st Department of Neurology, Faculty of Medicine, Comenius University, University Hospital, 81499 Bratislava, Slovakia $1 https://orcid.org/0000000225896363
773    0_
$w MED00186366 $t Life $x 2075-1729 $g Roč. 13, č. 2 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36836798 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20250507132403 $b ABA008
999    __
$a ok $b bmc $g 1922735 $s 1189204
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 13 $c 2 $e 20230204 $i 2075-1729 $m Life $n Life (Basel) $x MED00186366
LZP    __
$a Pubmed-20230413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...